Please use this identifier to cite or link to this item:
https://nslhd.intersearch.com.au/nslhdjspui/handle/1/42902| Title: | A Randomised Dose De-Escalation Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years: Final Analysis of Response and Toxicity | Authors: | Mulligan, Stephen P. ;Gill, Devinder;Turner, Paul;Renwick, William E. P.;Latimer, Maya;Mackinlay, Naomi J ;Berkahn, Leanne;Simpson, David;Campbell, Philip;Forsyth, Cecily J;Cull, Gavin;Harrup, Rosemary;Sulda, Melanie;Best, Giles;Bressel, Mathias;Di Iulio, Juliana;Kuss, Bryone J | Affiliation: | Royal North Shore Hospital | Issue Date: | Dec-2014 | Publication information: | 124 (21): 3325 | Journal: | Blood | URI: | https://nslhd.intersearch.com.au/nslhdjspui/handle/1/42902 | DOI: | 10.1182/blood.V124.21.3325.3325 | URL: | https://ashpublications.org/blood/article/124/21/3325/97519/A-Randomised-Dose-De-Escalation-Study-of-Oral | ISSN: | 0006-4971 1528-0020 |
Type: | Article |
| Appears in Collections: | Research Publications |
Show full item record
Items in NSLHD are protected by copyright, with all rights reserved, unless otherwise indicated.